Sign in Register

Erythrocin Stearate (erythromycin stearate)

Advertisement

Last reviewed · Source: First Databank (FDB) drug data

Overview

Erythromycin stearate is a macrolide antibiotic.

USES: Erythromycin is used to treat a wide variety of bacterial infections. It may also be used to prevent certain bacterial infections. Erythromycin is known as a macrolide antibiotic.

It works by stopping the growth of bacteria. This antibiotic treats or prevents only bacterial infections. It will not work for viral infections (such as common cold, flu).

Using any antibiotic when it is not needed can cause it to not work for future infections.

Generic name: erythromycin stearate
Pronunciation: (e-RITH-roe-MYE-sin base, e-RITH-roe-MYE-sin STEER-ate)

Reference product & biosimilars

No reference, biosimilar or interchangeable associated with this drug.

Today’s intelligence on Erythrocin Stearate

Intelligence content is not available yet.

Indications

The following indications are listed for Erythrocin Stearate:

  • Acute Bacterial Otitis Media
  • Acute Bacterial Sinusitis
  • Acute Streptococcal Pyogenes Bacterial Sinusitis
  • Acute Streptococcus Pneumoniae Bacterial Sinusitis
  • Bacterial Pneumonia
  • Chlamydia Cervicitis
  • Chlamydia Trachomatis Urethritis
  • Chlamydial Conjunctivitis
  • Chlamydial Pneumonia
  • Diphtheria
  • Diphtheria Carrier State
  • Erythrasma
  • Legionnaires' Disease
  • Listeriosis
  • Mycoplasmal Pneumonia
  • Neonatal Pneumonia
  • Nongonococcal Urethritis
  • Pertussis
  • Pharyngitis Due To Streptococcus Pyogenes
  • Pneumococcal Acute Otitis Media
  • Pneumococcal Pharyngitis
  • Pneumococcal Pneumonia
  • Post-Exposure Diphtheria Prevention
  • Preoperative Bowel Preparation
  • Rectal Chlamydia Trachomatis Infection
  • Rheumatic Fever Prevention
  • Skin And Skin Structure Infection
  • Skin And Skin Structure Streptococcus Pyogenes Infection
  • Staphylococcus Aureus Skin And Skin Structure Infection
  • Streptococcus Acute Otitis Media
  • Syphilis

Also known as: Acute Otitis Media Due To Diplococcus Pneumoniae, Acute Otitis Media Due To Fraenkel's Pneumococcus, Acute Otitis Media Due To Pneumococcus, Acute Otitis Media Due To Pneumonococcus, Acute Otitis Media Due To Streptococcus Pneumoniae, Acute Otitis Media Due To Streptococcus Species, Acute Sinusitis Due To Diplococcus Pneumoniae, Acute Sinusitis Due To Fraenkel's Pneumococcus, Acute Sinusitis Due To Fraenkel's Pneumonococcus, Acute Sinusitis Due To Group A Beta-Hemolytic Strep, Acute Sinusitis Due To Pneumococcus, Acute Sinusitis Due To Streptococcus Epidemicus, Acute Sinusitis Due To Streptococcus Pneumoniae, Acute Sinusitis Due To Streptococcus Pyogenes, Acute Sinusitis From Fraenkel-Weichselbaum Pneumococcus, Bacterial Otitis Media, Cervicitis Due To Chlamydia Trachomatis, Diphtheria Carrier, Diphtheritis, Diphtheritis Prophylaxis, Post-Exposure, Eaton Agent Pneumonia, Epidemic Sore Throat, Fraenkel-Weichselbaum Pneumococcus Acute Otitis Media, Infection Due To Listeria Monocytogenes, Infection Of Skin And/Or Subcutaneous Tissue, Infection Of The Lungs Due To Chlamydia, Legionellosis, Ngu Due To Chlamydia Trachomatis, Nongonococcal Urethritis Due To Chlamydia Trachomatis, Pharyngitis Due To Group A Beta-Hemolytic Streptococci, Pharyngitis Due To Streptococcus Epidemicus, Pharyngitis Due To Streptococcus Pneumoniae, Pneumonia Due To Streptococcus Pneumoniae, Post-Exposure Diphtheria Prophylaxis, Primary Atypical Pneumonia, Rectal Infection Due To Chlamydia Trachomatis, Rheumatic Fever Prophylaxis, Septic Sore Throat, Skin & Skin Soft Tissue Streptococcus Pyogenes Infection, Skin And Skin Soft Tissue Staphylococcus Aureus Infection, Skin And Soft Tissue Skin Infection, Streptococcal Pharyngitis, Syriac Ulcer, Syriac Ulcer Prophylaxis, Post-Exposure, Trachelitis Due To Chlamydia Trachomatis, Urethritis Due To Chlamydia Trachomatis.

Dosing

Dosage of erythromycin stearate is expressed in terms of erythromycin.

The usual adult dosage of erythromycin as the stearate is 250 mg every 6 hours or 500 mg every 12 hours. In severe infections, dosage in adults may be increased to 4 g or more daily. A twice-daily dosing schedule is not recommended when dosages greater than 1 g daily are administered; some clinicians believe the twice-daily schedule is inadequate for all but minor infections caused by highly susceptible organisms.

The usual erythromycin dosage in children is 30-50 mg/kg daily given in 2-4 equally divided doses. For more severe infections, this dosage may be doubled but should not exceed 4 g daily. An alternative pediatric dosage of 0.9-3 g/m2 daily given in 4 equally divided doses has been recommended. A twice-daily dosing schedule is not recommended when dosages greater than 1 g daily are administered; some clinicians believe the twice-daily schedule is inadequate for all but minor infections caused by highly susceptible organisms.

Drug interactions

There is no enhanced messaging for this drug.

Contraindications

There is no enhanced messaging for this drug.

Adverse reactions

There is no enhanced messaging for this drug.

Precautions

No enhanced messaging available.

ICD codes

No ICD codes are available for this drug.

Formulary status

Search health-plan coverage for this drug by ZIP code.

Enter a 5-digit ZIP code. Searching does not change your profile.

Enter a ZIP code to view available health plans.

Last reviewed · Source: First Databank (FDB) drug data